New remedy for rheumatoid arthritis will be offered by SUS
People with rheumatoid arthritis may have another medication to treatment in the Unified Health System (SUS): tofacitinibe citrate. The SUS has up to 180 days from the last Thursday (2) to make the medicine available in the country.
The remedy is indicated for adults with active, moderate to severe rheumatoid arthritis, with an inadequate response to one or more disease-modifying drugs. Rheumatoid arthritis is an autoimmune, inflammatory, systemic, and chronic disease. In Brazil, a 2004 study showed a prevalence of 0.46%, representing almost one million people with this disease.
The incidence of rheumatoid arthritis disease increases with age and the highest peak is between 30 and 50 years. The female sex is the most affected by the disease, about two to three times in relation to the male sex. If untreated, 20% to 30% of people with rheumatoid arthritis are permanently unable to perform their activities after about three years from diagnosis.
The product is Rekovelle®, which has as its active ingredient the substance deltafolitropin, a substance that is associated with the human Follicle Stimulating (FSH) hormone. This component allows the ovaries to be released from the ovary for fertilization, stimulating the ovaries to develop multiple follicles.
What comes to your head when you think of an open fracture? Most likely, it must be that idea of some part of the body with a broken bone coming out of the skin. Urgh! And, yes, it may be that way, however, in many cases the image is quite different, but the care should be equally rigorous. " The exposed fracture happens when the focus of the fracture has some communication with the external environment, when the inner part has a communication with the ambient air, even if minimally, it is already defined as exposed.